RADLogics™ Adds AI Applications Modified for COVID-19 to Nuance Marketplace
Software supports CT and X-ray chest imaging.
RADLogics™ announced this week it is bringing additional software to the Nuance AI Marketplace, adding its artificial intelligence (AI)-powered medical imaging applications designed for the detection and quantification of COVID-19 findings.
The Nuance AI Marketplace is the first and largest one-stop portal that provides access to a myriad of AI diagnostic models. With this move, radiologists in more than 7,000 healthcare facilities nationwide can access the software applications.
These new medical imaging applications join RADLogic’s other patient triage and disease extent measurement tools. According to a company statement, these solutions have the capability of processing 1 million CT scans and 10 million X-rays daily through the RADLogic cloud-based platform.
Based on company information, the AI-powered software includes algorithms that can detect abnormalities on chest CTs and X-rays, as well as trigger automatic triage alerts to ensure a radiologist sees critical findings quickly. The company has modified its algorithms to detect lung abnormalities in patients who might have COVID-19. The tools, company officials said, are designed to provide quantitative analysis of CTs and X-rays, as well as provide a score than can help track findings over time.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
